The patent (WO2018089602) THERAPEUTIC FOR THE PREVENTION AND/OR TREATMENT OF WEIGHT GAIN AND/OR DIABETES is currently under consideration
Compared to SGLT2 inhibitors, initiation of GLP-1RA was associated with higher risk of AF/Aflutter (HR: 1.46
Elevate your health with confidence, knowing you have a superior glutathione supplement dedicated to promoting vitality and resilience from the inside out
The expression levels (endogenous mRNA) of FBI-1 (G) and GPX4 (H) in PC clinical specimens are shown as scatter-bar images (G and H), and the correlation between FBI-1 and GPX4 in PC tissues (I) was determined
Coli, salmonella e altri criteri rilevanti
2010;11:87 Kitowska K, Zakrzewicz D, Knigshoff M, Chrobak I, Grimminger F, Seeger W, et al